RxDoctor Payments Data

John Miura, MD

Surgery · Philadelphia, PANPI 1225353279

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Iovance Biotherapeutics, Inc.. That places this record below the midpoint for surgery clinicians in PA, where the typical reported total is $1,143.

$66in general payments, 2019–2025

Across 1 payment — averaging $65.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Iovance Biotherapeutics, Inc.$66
$1,297,935in research payments, 2019–2025

Across 6 payments — averaging $216,322 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.3M

What the payments were for

  • Food & beverage$66100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Iovance Biotherapeutics, Inc.1$66

How this compares

$66 in reported general payments places this provider in the 10th percentile of 1,424 surgery providers in Pennsylvania.

See all surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$114,357
Medicare patients
199
Services billed
610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →